The prevalence of fatigue among patients with chronic obstructive pulmonary disease (COPD) worldwide is approximately 59%, according to systematic review and meta-analysis findings published in ...

In the 1980s, when Stella Kourembanas, MD, began her career in neonatology, she cared for newborns with pulmonary ...

High-risk acute pulmonary embolism affects around 5% of all pulmonary embolisms and can take a dramatic course even in young ...

Does gabapentinoid use increase the risk of severe exacerbation in patients with chronic obstructive pulmonary disease (COPD) ...

The company also highlighted that bronchiectasis is a chronic, progressive disease with no approved treatments, leaving hundreds of thousands of people in the U.S. without an effective way to reduce ...

SODIUM-GLUCOSE cotransporter-2 inhibitors (SGLT-2i) and glucagon-like peptide-1 receptor agonists (GLP-1RA) are associated with a reduced risk of moderate or severe chronic obstructive pulmonary ...

Four survived with chronic pulmonary disease. One of those who survived is still symptomatic, with diffuse, faint rales bilaterally, mild subcostal retraction and slight cyanosis when crying.

Chronic obstructive pulmonary disease (COPD) is a group of progressive lung diseases that obstruct airflow. You may experience breathing difficulties, but you can treat and even prevent flare-ups.

Chronic obstructive pulmonary disease (COPD) is a heterogeneous disease ... Summary: Frequent respiratory exacerbations may indicate escalation of treatment (ICS, biologics, azithromycin, roflumilast, ...

Statins may thus only associate with reduced risk of exacerbations in patients with COPD with coexisting cardiovascular disease. We tested the hypothesis ... the confounders of use of all maintenance ...